Brand / product

Werya

Sofosbuvir + Velpatasvir · 400 mg + 100 mg

₨ Official source-observed price PKR 9,232.93 14's

PKR 659.50 / tablet

✓ Official DRAP price source observed · Source checked 2026-10-09

Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →

This brandPKR 659.50/ tablet

Price position6% below medianvs like-for-like peer median

Peer comparators23current-price listings

🔒

MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence

View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic: Sofosbuvir + Velpatasvir
Therapeutic area: Anti-infectives
Drug class: Antivirals
ATC: J05AP
Strength: 400 mg + 100 mg
Dosage form: Tablet
Pack: 14's
Registration no.: 093378
Price record verified: 2026-08-24
Latest DRAP source check: 2026-10-09 03:22

Manufacturer

Werrick Pharmaceuticals

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

Summary

About Werya 400 mg + 100 mg tablet

Werya 400 mg + 100 mg tablet contains Sofosbuvir + Velpatasvir 400 mg + 100 mg. It is registered with DRAP by Werrick Pharmaceuticals (registration no. 093378). Its official price is PKR 9,232.93 for a pack of 14's, about PKR 659.50 per tablet. The price changed from PKR 8,798.29 to PKR 9,232.93 on 17 August 2026. Werya is also available as 400 mg tablet. 19 other brands of Sofosbuvir + Velpatasvir 400 mg + 100 mg (tablet) are registered in Pakistan. Compare all brands and prices →

Same brand

Other strengths of Werya

Werya 400 mgTablet · 28's · PKR 18,465.85

Same medicine and strength

Other brands of Sofosbuvir + Velpatasvir 400 mg + 100 mg

ABRIVA PLUS 400 mg + 100 mgCCL Pharmaceuticals (Pvt.) Limited · PKR 19,821.25 / 28's Bosovel 400 mg + 100 mgBosch Pharmaceuticals (Pvt) Ltd. · PKR 19,415.00 / 28's Cure-C Forte 400 mg + 100 mgGlobal Pharmaceuticals (Pvt.) Ltd. · PKR 12,392.20 / 28's Dowvir 400 mg + 100 mgMartin Dow Limited · PKR 19,821.26 / 28's Fosbu V 400 mg + 100 mgHighnoon Laboratories Ltd · PKR 16,057.26 / 28 Hepgard-V 400 mg + 100 mgBarrett Hodgson Pakistan (Pvt.) Ltd · PKR 17,235.87 / 28's HILVEL 400mg 400 mg + 100 mgHilton Pharma (Pvt) Limited. · PKR 20,364.34 / 28's Maclusa 400 mg + 100 mgMacter International Limited · PKR 20,176.07 / 28's

See all 19 brands of Sofosbuvir + Velpatasvir and compare prices →

Price movement

Official price over time

PKR 8,798.29 to 9,232.93 (+4.9%) between 18 Aug 2025 and 17 Aug 2026 · 2 official price records · pack 14's

Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.

Cite this price history

MedInfoBase. Werya 400 mg + 100 mg, 14's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/werya-400-mg-100-mg-093378-14s-werrick-pharmaceuticals/ (accessed 9 October 2026).

Traceability

Official price history

Amount	Effective from	Verified	Source	Status
PKR 9,232.93	2026-08-17	2026-08-24	DRAP PharmaPrice Index	Current
PKR 8,798.29	2025-08-18	2026-08-08	DRAP PharmaPrice Index	Historical

Same generic

Other listed brands

ABRIVA PLUS 400 mg + 100 mgCCL Pharmaceuticals (Pvt.) Limited · PKR 19,821.25 Bosovel 400 mg + 100 mgBosch Pharmaceuticals (Pvt) Ltd. · PKR 19,415.00 Cure-C Forte 400 mg + 100 mgGlobal Pharmaceuticals (Pvt.) Ltd. · PKR 12,392.20 Dowvir 400 mg + 100 mgMartin Dow Limited · PKR 19,821.26 Epclusa 100 mg + 400 mgFerozsons Laboratories Limited · PKR 72,137.00 Epclusa 100 mg + 400 mgFerozsons Laboratories Limited · PKR 61,317.23 Fosbu V 400 mg + 100 mgHighnoon Laboratories Ltd · PKR 16,057.26 Fosbu V 400 100 mg + 100 mgHighnoon Laboratories Ltd · PKR 7,557.78

Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 093378

MedInfoBase. (2026). Werya 400 mg + 100 mg Tablet (14's), Werrick Pharmaceuticals — registration and price record [Data set]. MedInfoBase. Retrieved October 9, 2026, from https://medinfobase.com/brand/werya-400-mg-100-mg-093378-14s-werrick-pharmaceuticals/ Data observed 24 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 093378.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.